Infection and remodelling: A 21st century model of bronchiectasis?

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 758-760

  Ward, C ^a   Rydell Tormanen K ^b   Westergren Thorsson, G ^c   Eriksson, L T ^c   Walters, H ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY REMODELING; ASTHMA; BACTERIAL COLONIZATION; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; HEMOPTYSIS; HUMAN; HYPOXIA; LUNG INFECTION; NEOVASCULARIZATION (PATHOLOGY); NEW ZEALAND; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; UNITED STATES;

ANIMALS; FEMALE; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053475356     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00072811     Document Type: Editorial

References (36)

1. O'Donnell AE. Bronchiectasis. Chest 2008; 134: 815-823.
2. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: Suppl. 1, i1-i58.
3. Laennec RTH. De l'Auscultation Mediate ou Traite du Diagnostic des Madadies des Poumons et du Coeur. [On Mediate Auscultation or Treatise on the Diagnosis of the Diseases of the Lungs and Heart.] Paris, Brosson and Chaudé, 1819.
4. Martin C, Thévenot G, Danel S, et al. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 2011; 38: 939-946.
5. Song JW, Im JG, Shim YS, et al. Hypertrophied bronchial artery at thin-section CT in patients with bronchiectasis: correlation with CT angiographic findings. Radiology 1998; 208: 187-191.
6. Yoo DH, Yoon CJ, Kang SG, et al. Bronchial and nonbronchial systemic artery embolization in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate. AJR Am J Roentgenol 2011; 196: W199-W204.
7. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001; 164: S39-S45.
8. Morrissey BM, Evans SJ. Severe bronchiectasis. Clin Rev Allergy Immunol 2003; 25: 233-247.
9. Khor YH, Teoh AK, Lam SM, et al. Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. Clin Exp Allergy 2009; 39: 1659-1667.
10. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001; 107: 1034-1038. (Pubitemid 32523344)
11. Orsida BE, Li X, Hickey B, et al. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54: 289-295. (Pubitemid 29150155)
12. Walters EH, Reid D, Soltani A, et al. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther 2008; 118: 128-137.
13. Feltis BN, Wignarajah D, Zheng L, et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006; 173: 1201-1207. (Pubitemid 43848389)
14. Langenbach SY, Zheng L, McWilliams T, et al. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2005; 24: 1550-1556. (Pubitemid 41396452)
15. Zheng L, Orsida BE, Ward C, et al. Airway vascular changes in lung allograft recipients. J Heart Lung Transplant 1999; 18: 231-238. (Pubitemid 29181748)
16. Anderson RL, Hiemstra PS, Ward C, et al. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 2008; 32: 670-677.
17. Koczulla R, Von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 1665-1672. (Pubitemid 38057748)
18. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
19. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-744. (Pubitemid 32230838)
20. Calabrese C, Bocchino V, Vatrella A, et al. Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Respir Med 2006; 100: 1415-1422. (Pubitemid 43942323)
21. Hiroshima K, Iyoda A, Shibuya K, et al. Evidence of neoangiogenesis and an increase in the number of proliferating cells within the bronchial epithelium of smokers. Cancer 2002; 95: 1539-1545.
22. Kranenburg AR, De Boer WI, Alagappan VK, et al. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 106-113. (Pubitemid 40222891)
23. Kanazawa H, Asai K, Hirata K, et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003; 114: 354-358. (Pubitemid 36513682)
24. Soltani A, Reid DW, Sohal SS, et al. Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 2010; 11: 105.
25. Bhattacharya J. Lung neovascularization: a tale of two circulations. Am J Physiol Lung Cell Mol Physiol 2008; 294: L417-L418. (Pubitemid 351468840)
26. Rydell-Tormanen K, Uller L, Erjefalt JS. Remodeling of extra-bronchial lung vasculature following allergic airway inflammation. Respir Res 2008; 9: 18.
27. Rydell-Tormanen K, Johnson JR, Fattouh R, et al. Induction of vascular remodeling in the lung by chronic house dust mite exposure. Am J Respir Cell Mol Biol 2008; 39: 61-67. (Pubitemid 351883959)
28. Rydell-Tormanen K, Uller L, Erjefalt JS. Allergic airway inflammation initiates long-term vascular remodeling of the pulmonary circulation. Int Arch Allergy Immunol 2009; 149: 251-258.
29. Daley E, Emson C, Guignabert C, et al. Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 2008; 205: 361-372. (Pubitemid 351281602)
30. Witzenrath M, Ahrens B, Kube SM, et al. Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur Respir J 2006; 28: 370-377. (Pubitemid 44914238)
31. Signorelli S, Jennings P, Leonard MO, et al. Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial cells. Cell Physiol Biochem 2009; 25: 135-144.
32. Gardner LB, Corn PG. Hypoxic regulation of mRNA expression. Cell Cycle 2008; 7: 1916-1924. (Pubitemid 352030334)
33. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005; 15: 57-63. (Pubitemid 40693388)
34. Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35: 233-245. (Pubitemid 40585309)
35. Andersson-Sjoland A, Erjefalt JS, Bjermer L, et al. Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis. Respir Res 2009; 10: 103.
36. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; 2010: 672395.